Costco Wholesale Corporation (COST) has recently garnered attention in the investment community after Chuck Cerankosky of Northcoast Research upgraded the stock to a “Buy” o. With a current trading ...

Summary • Elong Power Holding Limited’s stock fell 8.6% in after-hours trading to $0.1305 following a close at $0.1427.• The company announced a 16-for-1 reverse stock split during a special ...

Summary • Biohaven Ltd. shares dropped 16.6% to $9.02 in after-hours trading following a Phase 2 study update on BHV-7000 for major depressive disorder.• The clinical update revealed challenges ...

Summary • SOBR Safe, Inc. shares fell 17% in after-hours trading to $1.96 following a $2 million private placement announcement.• The company plans to issue 1,290,324 shares at $1.55 per share, which ...

Summary • Nuvve Holding Corp. shares rose 5.6% in after-hours trading following a strategic agreement.• The company signed a non-binding MOU with E&B Renewables to deploy Battery Energy Storage ...

Summary • Webus International Limited (WETO) fell 7.5% to $0.90 in after-hours trading despite announcing expansion into the U.S. outdoor smart equipment and robotics market.• The stock’s trading ...

Spire Global, Inc. (SPIR) garnered a Neutral rating from Brian Kinstlinger at Alliance Global Partners o. With a current stock price of $8.62 and a price target set at $17, investors are keenly ...

Summary • Trinity Biotech’s stock declined 15.6% to $1.08 during intraday trading without a clear catalyst.• The company announced agreements to improve its capital structure and secured a significant ...

Summary • Rezolute, Inc. shares rose 13.6% to $2.75 amidst ongoing investigations and legal concerns following a significant trial failure.• The stock has seen increased trading volume, with a notable ...

Summary • Omeros Corporation’s stock jumped 72.1% to $15.06 following FDA approval of Yartemlea, its therapy for TA-TMA.• Yartemlea is the first therapy targeting hematopoietic stem cell ...

Summary • Lexaria Bioscience Corp. (LEXX) shares fell 9.1% to $0.5633 despite recent successful clinical study results.• The company reported a significant reduction in side effects from its Phase 1b ...

Summary • Bone Biologics Corporation (BBLG) shares fell 10.1% to $1.75 amid investor selling pressure.• The company announced a manufacturing milestone, extending the shelf life of its rhNELL-1 ...